Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 61477-96-1
- Molecular formula
- C23H27N5O7S
- Molecular weight
- 517.6 g/mol
- Drug class
- Extended-spectrum ureidopenicillinbeta-lactam antibacterial agent
- Mechanism of action
- Binds penicillin-binding proteins and inhibits bacterial septum formation and cell-wall synthesis, resulting in bactericidal activity against susceptible organisms. It is commonly administered with tazobactam to inhibit susceptible beta-lactamases.
- Indications / reported uses
- Treatment of susceptible serious bacterial infections, including intra-abdominal, respiratory, skin/soft-tissue and other systemic infections; product combinations and indications depend on the specific authorised formulation.
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8db6bd91-2106-4bfd-8cc8-38aaf1e18d17 · https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623